Aurobindo Pharma Board approves ₹800 cr share buyback plan
Generic drugmaker is proposing to buyback more than 54.23 lakh equity shares at ₹1,475 each, fixes April 17, 2026 as the record date
What's Your Reaction?
Or register with email
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Kartavya News Mar 19, 2026 0
Total Vote: 0
Send Message on kartavyasolution@gmail.com
